Determining Which Patients Will Benefit from GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM

0.50 hr(s) | CME

Specialty: Diabetes

Therapeutic Area(s): Endocrinology

Release Date: July 16, 2021

Expiration Date: July 15, 2022

Location: Internet Activity Enduring

In this activity, an expert on type 2 diabetes mellitus (T2DM) discusses how GLP-1 RAs can be integrated into individualized treatment plans to improve outcomes for patients with T2DM.

Access this activity
Share via
Copy link
Powered by Social Snap